Evotec
Vincent Piras is a seasoned bioinformatics professional with extensive experience leading multidisciplinary teams and managing complex projects. Currently serving as Team Leader / Senior Research Scientist at Evotec since January 2019, Vincent oversees project delivery and client communications. Previous roles include Team Leader and Research Scientist at R++, Researcher at CNRS, and Lecturer at Université d'Evry-Val d'Essonne. With a strong foundation in systems biology and biostatistics developed during a Ph.D. at Keio University, Vincent has contributed significantly to the field through research, teaching, and the development of innovative bioinformatics tools and methodologies.
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.